2016
DOI: 10.1016/j.jstrokecerebrovasdis.2016.03.047
|View full text |Cite
|
Sign up to set email alerts
|

Stroke Thrombolysis Protocol Shortens “Door-to-Needle Time” and Improves Outcomes—Experience at a Tertiary Care Center in Qatar

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
32
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 17 publications
(33 citation statements)
references
References 7 publications
1
32
0
Order By: Relevance
“…22 Low mortality rates have also been attributed to a young Qatar population together with improvements in stroke management and care. 26 Although the findings of low incidence and mortality of stroke in Qatar suggest a low burden in the country, it is expected that as the population ages stroke will become a more prominent issue.…”
Section: Mortalitymentioning
confidence: 99%
See 1 more Smart Citation
“…22 Low mortality rates have also been attributed to a young Qatar population together with improvements in stroke management and care. 26 Although the findings of low incidence and mortality of stroke in Qatar suggest a low burden in the country, it is expected that as the population ages stroke will become a more prominent issue.…”
Section: Mortalitymentioning
confidence: 99%
“…Reducing ‘door-to-needle time’ may lead to considerable benefits including higher rates of thrombolysis, fewer complications, shorter length of stay in hospitals and improved prognosis for patients. 26…”
Section: Stroke Care and Outcomementioning
confidence: 99%
“…Infarction in the middle cerebral artery (MCA) territory is a common and severe ischemic stroke (1,2). The lesion volume, as assessed on diffusion-weighted imaging (DWI), is a recognized imaging biomarker for outcome forecasting; it is also an indicator which can guide the patient’s thrombolytic and endovascular treatment (3,4).…”
Section: Introductionmentioning
confidence: 99%
“…Currently, one of a few evidence-based acute stroke treatments is thrombolysis induced by intravenous administration of recombinant tissue plasminogen activator (tPA). Unfortunately, only a small percentage of patients benefit from this treatment primarily due to a narrow therapeutic time window of 4.5 hours [13]. …”
Section: Introductionmentioning
confidence: 99%